PROTAMINE SULFATE
Substance profile for UNII 0DE9724IHC, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.
Substance Identity#
- UNII
- 0DE9724IHC
- Preferred term
- PROTAMINE SULFATE
- Registry number
- 9009-65-8
- Ingredient type
- INGREDIENT SUBSTANCE
Chemical And Database Identifiers#
- RxCUI
- 8825
- PubChem
- 0
- NCIt
- C84123
- INN ID
- 717
DailyMed Socrata Ingredients#
Type, DailyMed label, SPL version table| Type | DailyMed label | SPL version |
|---|
| INACTIVE INGREDIENT | Novolin 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin) ® | 2 |
| INACTIVE INGREDIENT | Novolin N NPH, Human Insulin Isophane Suspension (recombinant DNA origin) 100 units/mL | 2 |
| INACTIVE INGREDIENT | Novolin ® 70/30, 70% NPH, Human Insulin Isophane Suspension and 30% Regular, Human Insulin Injection (recombinant DNA origin) | 2 |
| INACTIVE INGREDIENT | These highlights do not include all the information needed to use NovoLog Mix 70/30 safely and effectively. See full prescribing information for NovoLog Mix 70/30. NovoLog® Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin]) Suspension for subcutaneous injection Initial U.S. Approval: 2001 | 2 |
| INACTIVE INGREDIENT | 81f28314-31c8-4114-a4b3-336eb2094558 | 1 |
| INACTIVE INGREDIENT | 44863566-b55c-422d-adbd-5454a70b68a9 | 1 |
| INACTIVE INGREDIENT | HUMALOG MIX50/50 (INSULIN LISPRO) INJECTION, SUSPENSION HUMALOG MIX50/50 KWIKPEN (INSULIN LISPRO) INJECTION, SUSPENSION [ELI LILLY AND COMPANY] | 32 |
| INACTIVE INGREDIENT | HUMALOG MIX75/25 (INSULIN LISPRO) INJECTION, SUSPENSION HUMALOG MIX75/25 KWIKPEN (INSULIN LISPRO) INJECTION, SUSPENSION [ELI LILLY AND COMPANY
] | 31 |
| INACTIVE INGREDIENT | NOVOLOG MIX 70/30 (INSULIN ASPART) INJECTION, SUSPENSION [NOVO NORDISK] | 16 |
| INACTIVE INGREDIENT | NOVOLIN N (HUMAN INSULIN) INJECTION, SUSPENSION [NOVO NORDISK] | 10 |
| INACTIVE INGREDIENT | NOVOLIN 70/30 (HUMAN INSULIN) INJECTION, SUSPENSION [NOVO NORDISK] | 9 |
| ACTIVE INGREDIENT | PROTAMINE SULFATE INJECTION, SOLUTION [CARDINAL HEALTH] | 2 |
| ACTIVE INGREDIENT | PROTAMINE SULFATE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 2 |
| INACTIVE INGREDIENT | HUMULIN 70/30 70/30 (INSULIN HUMAN) INJECTION, SUSPENSION [REMEDYREPACK INC. ] | 1 |
| INACTIVE INGREDIENT | HUMULIN 70/30 70/30 (INSULIN HUMAN) INJECTION, SUSPENSION [REMEDYREPACK INC. ] | 1 |
| INACTIVE INGREDIENT | NOVOLIN 70/30 (HUMAN INSULIN) INJECTION, SUSPENSION [A-S MEDICATION SOLUTIONS LLC] | 1 |
| INACTIVE INGREDIENT | NOVOLIN70/30 70/30 (HUMAN INSULIN) INJECTION, SUSPENSION [REMEDYREPACK INC. ] | 1 |
| INACTIVE INGREDIENT | NOVOLIN70/30 70/30 (HUMAN INSULIN) INJECTION, SUSPENSION [REMEDYREPACK INC. ] | 1 |
| ACTIVE INGREDIENT | PROTAMINE SULFATE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 |
| ACTIVE INGREDIENT | PROTAMINE SULFATE INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 |
mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=8825
ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C84123
precision.fda.gov/uniisearch/srs/unii/0DE9724IHC